Endocrine Management of Prostatic Cancer / / H. Klosterhalfen.
Saved in:
Superior document: | Title is part of eBook package: De Gruyter DGBA Medicine and Life Sciences - <1990 |
---|---|
HerausgeberIn: | |
: | |
Place / Publishing House: | Berlin ;, Boston : : De Gruyter, , [2019] ©1988 |
Year of Publication: | 2019 |
Edition: | Reprint 2019 |
Language: | German |
Series: | New Developments in Biosciences ;
4 |
Online Access: | |
Physical Description: | 1 online resource (137 p.) :; Num. figs. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
9783110853674 |
---|---|
ctrlnum |
(DE-B1597)54261 (OCoLC)1105858979 |
collection |
bib_alma |
record_format |
marc |
spelling |
Endocrine Management of Prostatic Cancer / H. Klosterhalfen. Reprint 2019 Berlin ; Boston : De Gruyter, [2019] ©1988 1 online resource (137 p.) : Num. figs. text txt rdacontent computer c rdamedia online resource cr rdacarrier text file PDF rda New Developments in Biosciences ; 4 Frontmatter -- Contents -- I. Mechanism of hormonal action at cellular level and biochemistry -- Mechanism and effects of androgen withdrawal therapies / Bruchovsky, N. / Rennie, P. S. / Goldenberg, S. L. -- Target-cell response to androgen withdrawal / Voigt, K. D. / Klein, H. -- Effects of chronic treatment with an LH-RH agonist on human testis tissue / Huhtaniemi, I. T. -- Animal models for prostate cancer / Otto, U. / Wagner, B. / Kloppel, G. / Baisch, H. / Klosterhalfen, H. -- The significance of the nude mice model for studies on human prostatic carcinoma / Steenbrugge, G. J. van / Jong, F. H. de / Gallee, M. P. W. / Schroder, F. H. -- II. Etiology and experimental basis of therapy -- Etiology and natural history of early prostatic cancer / Schröder, F. H. -- Pharmacological basis of androgen deprivation by various antiandrogens and their combination with LH-RH agonists / Neumann, F. / El Etreby, M. F. / Habenicht, U.-F. / Radlmaier, A. / Bormacher, K. -- III. Clinics -- Evaluation of different endocrine approaches in the treatment of prostatic carcinoma / Turkes, A. O. / Peeling, W. B. / Wilson, D. W. / Griffiths, K. -- Rationale of total androgen blockade by cyproterone acetate / Tunn, U. W. -- Clinical experience with Androcur® in the treatment of prostatic cancer / Becker, H. / Klosterhalfen, H. -- Prostate cancer treatment: tolerance of different endocrine regimens / Varenhorst, E. -- Result of long-term treatment with cyproterone acetate (CPA) in advanced prostatic cancer patients / Di Silverio, F. / Sciarra, F. -- Results and experience with the androgen ablation therapy: current trends in the USA / Kirchheim, D. -- Long-term results of an LH-RH agonist monotherapy in patients with carcinoma of the prostate and reflections on the so-called total androgen blockade with pre-medicated cyproterone acetate / Jacobi, G. H. -- List of first-mentioned contributors restricted access http://purl.org/coar/access_right/c_16ec online access with authorization star Mode of access: Internet via World Wide Web. In German. Description based on online resource; title from PDF title page (publisher's Web site, viewed 21. Dez 2019) Hormontherapie. Modell. Prostatakrebs. MEDICAL / Clinical Medicine. bisacsh Klosterhalfen, H., editor. edt http://id.loc.gov/vocabulary/relators/edt. Title is part of eBook package: De Gruyter DGBA Medicine and Life Sciences - <1990 9783110637861 ZDB-23-GML print 9783110115130 https://doi.org/10.1515/9783110853674 Cover https://www.degruyter.com/cover/covers/9783110853674.jpg |
language |
German |
format |
eBook |
author2 |
Klosterhalfen, H., Klosterhalfen, H., |
author_facet |
Klosterhalfen, H., Klosterhalfen, H., |
author2_variant |
h k hk h k hk |
author2_role |
HerausgeberIn |
author_sort |
Klosterhalfen, H., |
author_additional |
Bruchovsky, N. / Rennie, P. S. / Goldenberg, S. L. -- Voigt, K. D. / Klein, H. -- Huhtaniemi, I. T. -- Otto, U. / Wagner, B. / Kloppel, G. / Baisch, H. / Klosterhalfen, H. -- Steenbrugge, G. J. van / Jong, F. H. de / Gallee, M. P. W. / Schroder, F. H. -- Schröder, F. H. -- Neumann, F. / El Etreby, M. F. / Habenicht, U.-F. / Radlmaier, A. / Bormacher, K. -- Turkes, A. O. / Peeling, W. B. / Wilson, D. W. / Griffiths, K. -- Tunn, U. W. -- Becker, H. / Klosterhalfen, H. -- Varenhorst, E. -- Di Silverio, F. / Sciarra, F. -- Kirchheim, D. -- Jacobi, G. H. -- |
title |
Endocrine Management of Prostatic Cancer / |
spellingShingle |
Endocrine Management of Prostatic Cancer / New Developments in Biosciences ; Frontmatter -- Contents -- I. Mechanism of hormonal action at cellular level and biochemistry -- Mechanism and effects of androgen withdrawal therapies / Target-cell response to androgen withdrawal / Effects of chronic treatment with an LH-RH agonist on human testis tissue / Animal models for prostate cancer / The significance of the nude mice model for studies on human prostatic carcinoma / II. Etiology and experimental basis of therapy -- Etiology and natural history of early prostatic cancer / Pharmacological basis of androgen deprivation by various antiandrogens and their combination with LH-RH agonists / III. Clinics -- Evaluation of different endocrine approaches in the treatment of prostatic carcinoma / Rationale of total androgen blockade by cyproterone acetate / Clinical experience with Androcur® in the treatment of prostatic cancer / Prostate cancer treatment: tolerance of different endocrine regimens / Result of long-term treatment with cyproterone acetate (CPA) in advanced prostatic cancer patients / Results and experience with the androgen ablation therapy: current trends in the USA / Long-term results of an LH-RH agonist monotherapy in patients with carcinoma of the prostate and reflections on the so-called total androgen blockade with pre-medicated cyproterone acetate / List of first-mentioned contributors |
title_full |
Endocrine Management of Prostatic Cancer / H. Klosterhalfen. |
title_fullStr |
Endocrine Management of Prostatic Cancer / H. Klosterhalfen. |
title_full_unstemmed |
Endocrine Management of Prostatic Cancer / H. Klosterhalfen. |
title_auth |
Endocrine Management of Prostatic Cancer / |
title_alt |
Frontmatter -- Contents -- I. Mechanism of hormonal action at cellular level and biochemistry -- Mechanism and effects of androgen withdrawal therapies / Target-cell response to androgen withdrawal / Effects of chronic treatment with an LH-RH agonist on human testis tissue / Animal models for prostate cancer / The significance of the nude mice model for studies on human prostatic carcinoma / II. Etiology and experimental basis of therapy -- Etiology and natural history of early prostatic cancer / Pharmacological basis of androgen deprivation by various antiandrogens and their combination with LH-RH agonists / III. Clinics -- Evaluation of different endocrine approaches in the treatment of prostatic carcinoma / Rationale of total androgen blockade by cyproterone acetate / Clinical experience with Androcur® in the treatment of prostatic cancer / Prostate cancer treatment: tolerance of different endocrine regimens / Result of long-term treatment with cyproterone acetate (CPA) in advanced prostatic cancer patients / Results and experience with the androgen ablation therapy: current trends in the USA / Long-term results of an LH-RH agonist monotherapy in patients with carcinoma of the prostate and reflections on the so-called total androgen blockade with pre-medicated cyproterone acetate / List of first-mentioned contributors |
title_new |
Endocrine Management of Prostatic Cancer / |
title_sort |
endocrine management of prostatic cancer / |
series |
New Developments in Biosciences ; |
series2 |
New Developments in Biosciences ; |
publisher |
De Gruyter, |
publishDate |
2019 |
physical |
1 online resource (137 p.) : Num. figs. |
edition |
Reprint 2019 |
contents |
Frontmatter -- Contents -- I. Mechanism of hormonal action at cellular level and biochemistry -- Mechanism and effects of androgen withdrawal therapies / Target-cell response to androgen withdrawal / Effects of chronic treatment with an LH-RH agonist on human testis tissue / Animal models for prostate cancer / The significance of the nude mice model for studies on human prostatic carcinoma / II. Etiology and experimental basis of therapy -- Etiology and natural history of early prostatic cancer / Pharmacological basis of androgen deprivation by various antiandrogens and their combination with LH-RH agonists / III. Clinics -- Evaluation of different endocrine approaches in the treatment of prostatic carcinoma / Rationale of total androgen blockade by cyproterone acetate / Clinical experience with Androcur® in the treatment of prostatic cancer / Prostate cancer treatment: tolerance of different endocrine regimens / Result of long-term treatment with cyproterone acetate (CPA) in advanced prostatic cancer patients / Results and experience with the androgen ablation therapy: current trends in the USA / Long-term results of an LH-RH agonist monotherapy in patients with carcinoma of the prostate and reflections on the so-called total androgen blockade with pre-medicated cyproterone acetate / List of first-mentioned contributors |
isbn |
9783110853674 9783110637861 9783110115130 |
url |
https://doi.org/10.1515/9783110853674 https://www.degruyter.com/cover/covers/9783110853674.jpg |
illustrated |
Not Illustrated |
doi_str_mv |
10.1515/9783110853674 |
oclc_num |
1105858979 |
work_keys_str_mv |
AT klosterhalfenh endocrinemanagementofprostaticcancer |
status_str |
n |
ids_txt_mv |
(DE-B1597)54261 (OCoLC)1105858979 |
carrierType_str_mv |
cr |
hierarchy_parent_title |
Title is part of eBook package: De Gruyter DGBA Medicine and Life Sciences - <1990 |
is_hierarchy_title |
Endocrine Management of Prostatic Cancer / |
container_title |
Title is part of eBook package: De Gruyter DGBA Medicine and Life Sciences - <1990 |
author2_original_writing_str_mv |
noLinkedField noLinkedField |
_version_ |
1770177916610543616 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04134nam a22006375i 4500</leader><controlfield tag="001">9783110853674</controlfield><controlfield tag="003">DE-B1597</controlfield><controlfield tag="005">20191221113333.0</controlfield><controlfield tag="006">m|||||o||d||||||||</controlfield><controlfield tag="007">cr || ||||||||</controlfield><controlfield tag="008">191221s2019 gw fo d z ger d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783110853674</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1515/9783110853674</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-B1597)54261</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1105858979</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-B1597</subfield><subfield code="b">eng</subfield><subfield code="c">DE-B1597</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">ger</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">DE</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED014000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Endocrine Management of Prostatic Cancer /</subfield><subfield code="c">H. Klosterhalfen.</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">Reprint 2019</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Berlin ;</subfield><subfield code="a">Boston : </subfield><subfield code="b">De Gruyter, </subfield><subfield code="c">[2019]</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">©1988</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (137 p.) :</subfield><subfield code="b">Num. figs.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="347" ind1=" " ind2=" "><subfield code="a">text file</subfield><subfield code="b">PDF</subfield><subfield code="2">rda</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">New Developments in Biosciences ;</subfield><subfield code="v">4</subfield></datafield><datafield tag="505" ind1="0" ind2="0"><subfield code="t">Frontmatter -- </subfield><subfield code="t">Contents -- </subfield><subfield code="t">I. Mechanism of hormonal action at cellular level and biochemistry -- </subfield><subfield code="t">Mechanism and effects of androgen withdrawal therapies / </subfield><subfield code="r">Bruchovsky, N. / Rennie, P. S. / Goldenberg, S. L. -- </subfield><subfield code="t">Target-cell response to androgen withdrawal / </subfield><subfield code="r">Voigt, K. D. / Klein, H. -- </subfield><subfield code="t">Effects of chronic treatment with an LH-RH agonist on human testis tissue / </subfield><subfield code="r">Huhtaniemi, I. T. -- </subfield><subfield code="t">Animal models for prostate cancer / </subfield><subfield code="r">Otto, U. / Wagner, B. / Kloppel, G. / Baisch, H. / Klosterhalfen, H. -- </subfield><subfield code="t">The significance of the nude mice model for studies on human prostatic carcinoma / </subfield><subfield code="r">Steenbrugge, G. J. van / Jong, F. H. de / Gallee, M. P. W. / Schroder, F. H. -- </subfield><subfield code="t">II. Etiology and experimental basis of therapy -- </subfield><subfield code="t">Etiology and natural history of early prostatic cancer / </subfield><subfield code="r">Schröder, F. H. -- </subfield><subfield code="t">Pharmacological basis of androgen deprivation by various antiandrogens and their combination with LH-RH agonists / </subfield><subfield code="r">Neumann, F. / El Etreby, M. F. / Habenicht, U.-F. / Radlmaier, A. / Bormacher, K. -- </subfield><subfield code="t">III. Clinics -- </subfield><subfield code="t">Evaluation of different endocrine approaches in the treatment of prostatic carcinoma / </subfield><subfield code="r">Turkes, A. O. / Peeling, W. B. / Wilson, D. W. / Griffiths, K. -- </subfield><subfield code="t">Rationale of total androgen blockade by cyproterone acetate / </subfield><subfield code="r">Tunn, U. W. -- </subfield><subfield code="t">Clinical experience with Androcur® in the treatment of prostatic cancer / </subfield><subfield code="r">Becker, H. / Klosterhalfen, H. -- </subfield><subfield code="t">Prostate cancer treatment: tolerance of different endocrine regimens / </subfield><subfield code="r">Varenhorst, E. -- </subfield><subfield code="t">Result of long-term treatment with cyproterone acetate (CPA) in advanced prostatic cancer patients / </subfield><subfield code="r">Di Silverio, F. / Sciarra, F. -- </subfield><subfield code="t">Results and experience with the androgen ablation therapy: current trends in the USA / </subfield><subfield code="r">Kirchheim, D. -- </subfield><subfield code="t">Long-term results of an LH-RH agonist monotherapy in patients with carcinoma of the prostate and reflections on the so-called total androgen blockade with pre-medicated cyproterone acetate / </subfield><subfield code="r">Jacobi, G. H. -- </subfield><subfield code="t">List of first-mentioned contributors</subfield></datafield><datafield tag="506" ind1="0" ind2=" "><subfield code="a">restricted access</subfield><subfield code="u">http://purl.org/coar/access_right/c_16ec</subfield><subfield code="f">online access with authorization</subfield><subfield code="2">star</subfield></datafield><datafield tag="538" ind1=" " ind2=" "><subfield code="a">Mode of access: Internet via World Wide Web.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">In German.</subfield></datafield><datafield tag="588" ind1="0" ind2=" "><subfield code="a">Description based on online resource; title from PDF title page (publisher's Web site, viewed 21. Dez 2019)</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Hormontherapie.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Modell.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Prostatakrebs.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Clinical Medicine.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Klosterhalfen, H., </subfield><subfield code="e">editor.</subfield><subfield code="4">edt</subfield><subfield code="4">http://id.loc.gov/vocabulary/relators/edt.</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Title is part of eBook package:</subfield><subfield code="d">De Gruyter</subfield><subfield code="t">DGBA Medicine and Life Sciences - <1990</subfield><subfield code="z">9783110637861</subfield><subfield code="o">ZDB-23-GML</subfield></datafield><datafield tag="776" ind1="0" ind2=" "><subfield code="c">print</subfield><subfield code="z">9783110115130</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1515/9783110853674</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="3">Cover</subfield><subfield code="u">https://www.degruyter.com/cover/covers/9783110853674.jpg</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">EBA_BACKALL</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">EBA_CL_MDPM</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">EBA_DGALL</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">EBA_EBKALL</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">EBA_STMALL</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV-deGruyter-alles</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">PDA12STME</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">PDA14ALL</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">PDA15STM</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">PDA1ALL</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">PDA3STM</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">PDA5EBK</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-23-GML</subfield><subfield code="b">1990</subfield></datafield></record></collection> |